Mealey's (September 7, 2017, 1:37 PM EDT) -- SAN JOSE, Calif. — On the heels of his ruling from the bench to limit the class definition for a securities class action lawsuit against a medical technology developer and certain of its current and former executive officers, a federal magistrate judge on Sept. 6 issued a written ruling explaining his decision to limit the class definition to including only “indirect” investors in the company’s stock (Robert Colman, et al. v. Theranos Inc., et al., No. 16-6822, N.D. Calif.)....